For development of a continuous manufacturing process for biosimilar monoclonal antibody therapeutic
Lupin announced the signing of an agreement with CSIR-National Chemical Laboratory (CSIR-NCL, Pune) and Department of Science and Technology, (DST, Delhi) for conducting research on a continuous purification process development of a biosimilar monoclonal antibody therapeutic.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
